499 related articles for article (PubMed ID: 17039566)
1. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
[TBL] [Abstract][Full Text] [Related]
2. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis.
Totsuka T; Kanai T; Iiyama R; Uraushihara K; Yamazaki M; Okamoto R; Hibi T; Tezuka K; Azuma M; Akiba H; Yagita H; Okumura K; Watanabe M
Gastroenterology; 2003 Feb; 124(2):410-21. PubMed ID: 12557147
[TBL] [Abstract][Full Text] [Related]
3. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
4. ICOS/B7RP-1 interference in mouse kidney transplantation.
Lutz J; Lu R; Strobl M; Huang H; Deng M; Wang M; Ouyang N; Heemann U
Transplantation; 2007 Jul; 84(2):223-30. PubMed ID: 17667814
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
6. Contribution of B7RP-1/ICOS co-stimulation to lethal acute GVHD.
Fujimura J; Takeda K; Kaduka Y; Saito M; Akiba H; Yagita H; Yamashiro Y; Shimizu T; Okumura K
Pediatr Transplant; 2010 Jun; 14(4):540-8. PubMed ID: 20136724
[TBL] [Abstract][Full Text] [Related]
7. T-cell co-stimulation through B7RP-1 and ICOS.
Yoshinaga SK; Whoriskey JS; Khare SD; Sarmiento U; Guo J; Horan T; Shih G; Zhang M; Coccia MA; Kohno T; Tafuri-Bladt A; Brankow D; Campbell P; Chang D; Chiu L; Dai T; Duncan G; Elliott GS; Hui A; McCabe SM; Scully S; Shahinian A; Shaklee CL; Van G; Mak TW; Senaldi G
Nature; 1999 Dec; 402(6763):827-32. PubMed ID: 10617205
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of inducible costimulator on peripheral blood CD4+ T cells in Behçet's patients with uveitis: a new activity marker?
Usui Y; Takeuchi M; Yamakawa N; Takeuchi A; Kezuka T; Ma J; Matsuda R; Okunuki Y; Akiba H; Goto H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5099-104. PubMed ID: 20445113
[TBL] [Abstract][Full Text] [Related]
10. ICOS costimulates invariant NKT cell activation.
Kaneda H; Takeda K; Ota T; Kaduka Y; Akiba H; Ikarashi Y; Wakasugi H; Kronenberg M; Kinoshita K; Yagita H; Okumura K
Biochem Biophys Res Commun; 2005 Feb; 327(1):201-7. PubMed ID: 15629449
[TBL] [Abstract][Full Text] [Related]
11. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
12. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
13. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
Laliotou B; Duncan L; Dick AD
J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024
[TBL] [Abstract][Full Text] [Related]
14. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
[TBL] [Abstract][Full Text] [Related]
15. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
16. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
Xu H; Rizzo LV; Silver PB; Caspi RR
Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
[TBL] [Abstract][Full Text] [Related]
17. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
[TBL] [Abstract][Full Text] [Related]
18. [Translational research with experimental autoimmune uveoretinitis (EAU)].
Usui M
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):137-58; discussion 159. PubMed ID: 17402560
[TBL] [Abstract][Full Text] [Related]
19. ICOS and B7 costimulatory molecule expression identifies activated cellular subsets in rheumatoid arthritis.
Ruth JH; Rottman JB; Kingsbury GA; Coyle AJ; Haines GK; Pope RM; Koch AE
Cytometry A; 2007 May; 71(5):317-26. PubMed ID: 17323353
[TBL] [Abstract][Full Text] [Related]
20. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
Wong SC; Tan AH; Lam KP
Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
